G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value*

Author： Cho N.H.   Lim S.Y.   Kim Y.T.   Kim D.   Kim Y.S.   Kim J.W.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.90, Iss.1, 2003-07, pp. : 15-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenovirus-Mediated Transfer of HPV 16 E6/E7 Antisense RNA to Human Cervical Cancer Cells

By Hamada K.   Sakaue M.   Alemany R.   Zhang W.W.   Horio Y.   Roth J.A.   Mitchell M.F.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 219-227

Academic Press

Access to resources Recommend Favorite

Effect of BPV1 E2-Mediated Inhibition of E6/E7 Expression in HPV16-Positive Cervical Carcinoma Cells

By Moon M.S.   Lee C.J.   Um S.J.   Park J.S.   Yang J.M.   Hwang E.S.  

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 168-175

Elsevier

Access to resources Recommend Favorite

Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation

By Huang H.   Li C.-Y.   Little J. B.  

International Journal of Radiation Biology, Vol. 70, Iss. 2, 1996-08 ,pp. : 151-160

Informa Healthcare

Access to resources Recommend Favorite

Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer

By      

Molecular Medicine Reports, Vol. 6, Iss. 3, 2012-01 ,pp. : 473-476

Spandidos Publications

Access to resources Recommend Favorite

Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling

By Thomas Christoforos   Strom Anders   Lindberg Karolina   Gustafsson Jan-Ake  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 417-427

Springer Publishing Company

Access to resources Recommend Favorite